0001209191-22-018820.txt : 20220315
0001209191-22-018820.hdr.sgml : 20220315
20220315162717
ACCESSION NUMBER: 0001209191-22-018820
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220314
FILED AS OF DATE: 20220315
DATE AS OF CHANGE: 20220315
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Valamehr Bahram
CENTRAL INDEX KEY: 0001748177
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36076
FILM NUMBER: 22741472
MAIL ADDRESS:
STREET 1: C/O FATE THERAPEUTICS, INC.
STREET 2: 3535 GENERAL ATOMICS COURT, STE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: FATE THERAPEUTICS INC
CENTRAL INDEX KEY: 0001434316
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 651311552
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12278 SCRIPPS SUMMIT DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92131
BUSINESS PHONE: 858.875.1803
MAIL ADDRESS:
STREET 1: 12278 SCRIPPS SUMMIT DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92131
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-03-14
0
0001434316
FATE THERAPEUTICS INC
FATE
0001748177
Valamehr Bahram
C/O FATE THERAPEUTICS, INC.
12278 SCRIPPS SUMMIT DRIVE
SAN DIEGO
CA
92131
0
1
0
0
Chief R&D Officer
Common Stock
2022-03-14
4
M
0
25000
2.73
A
204834
D
Common Stock
2022-03-14
4
S
0
16678
30.36
D
188156
D
Common Stock
2022-03-14
4
S
0
3067
31.66
D
185089
D
Common Stock
2022-03-14
4
S
0
2195
32.49
D
182894
D
Common Stock
2022-03-14
4
S
0
2960
33.30
D
179934
D
Common Stock
2022-03-14
4
S
0
100
34.04
D
179834
D
Stock Option (Right to Buy)
2.73
2022-03-14
4
M
0
25000
0.00
D
2027-01-04
Common Stock
25000
36156
D
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 9, 2020.
Represents the weighted average sale price of the shares sold from $30.00 to $30.98 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of he Issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 through 5.
Represents the weighted average sale price of the shares sold from $31.00 to $31.99 per share.
Represents the weighted average sale price of the shares sold from $32.00 to $32.99 per share.
Represents the weighted average sale price of the shares sold from $33.00 to $33.91 per share.
This option is fully vested.
/s/ Cindy Tahl, as Attorney-in-Fact
2022-03-15